FI906411A0 - Foerhindring av cellfoeroekning med decorin. - Google Patents
Foerhindring av cellfoeroekning med decorin.Info
- Publication number
- FI906411A0 FI906411A0 FI906411A FI906411A FI906411A0 FI 906411 A0 FI906411 A0 FI 906411A0 FI 906411 A FI906411 A FI 906411A FI 906411 A FI906411 A FI 906411A FI 906411 A0 FI906411 A0 FI 906411A0
- Authority
- FI
- Finland
- Prior art keywords
- decorin
- foerhindring
- cellfoeroekning
- med
- suppress
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4725—Proteoglycans, e.g. aggreccan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21270288A | 1988-06-28 | 1988-06-28 | |
PCT/US1989/002770 WO1990000194A1 (en) | 1988-06-28 | 1989-06-23 | Suppression of cell proliferation by decorin |
Publications (1)
Publication Number | Publication Date |
---|---|
FI906411A0 true FI906411A0 (fi) | 1990-12-27 |
Family
ID=22792114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI906411A FI906411A0 (fi) | 1988-06-28 | 1990-12-27 | Foerhindring av cellfoeroekning med decorin. |
Country Status (11)
Country | Link |
---|---|
US (2) | US5726149A (ja) |
EP (1) | EP0349480B1 (ja) |
JP (3) | JP2887325B2 (ja) |
AT (1) | ATE120235T1 (ja) |
AU (1) | AU633011B2 (ja) |
CA (1) | CA1340112C (ja) |
DE (1) | DE68921803T2 (ja) |
DK (1) | DK306890D0 (ja) |
ES (1) | ES2070926T3 (ja) |
FI (1) | FI906411A0 (ja) |
WO (1) | WO1990000194A1 (ja) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5583103A (en) * | 1988-06-28 | 1996-12-10 | La Jolla Cancer Research Foundation | Inhibition of transforming growth factor beta activity |
US6509314B1 (en) * | 1988-06-28 | 2003-01-21 | The Burnham Institute | Methods of preventing or reducing scarring with decorin or biglycan |
US5654270A (en) | 1988-06-28 | 1997-08-05 | La Jolla Cancer Research Foundation | Use of fibromodulin to prevent or reduce dermal scarring |
EP0667784B1 (en) * | 1991-11-14 | 2003-03-05 | La Jolla Cancer Research Foundation | Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
US5830847A (en) * | 1992-10-30 | 1998-11-03 | Hsc Research & Development Limited Partnership | Soluble TGF-β-binding endoglin polypeptides and homodimers |
US5650389A (en) * | 1993-03-01 | 1997-07-22 | University Of Alabama At Birmingham Research Foundation | Methods for the inhibition of complement activation |
US5453492A (en) * | 1993-07-28 | 1995-09-26 | La Jolla Cancer Research Foundation | 60 kDa transforming growth factor-β-binding protein and its use to detect or purify TGF-β |
US5567807A (en) * | 1994-07-08 | 1996-10-22 | La Jolla Cancer Research Foundation | Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
JP2001520877A (ja) | 1997-10-28 | 2001-11-06 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 血管平滑筋細胞のインビトロ分化、それに関する方法および試薬 |
NZ522971A (en) * | 2000-05-05 | 2005-02-25 | Gtc Biotherapeutics Inc | Transgenically produced decorin in the mammary gland of a transgenic animal |
NZ532427A (en) | 2001-09-24 | 2008-07-31 | Imp Innovations Ltd | Modification of feeding behavior using PYY (peptide YY) and its agonists such as NPY (neuropeptide Y) |
AU2003201998C1 (en) | 2002-01-10 | 2012-10-25 | Imperial Innovations Limited | Modification of feeding behavior |
JP4564261B2 (ja) * | 2002-01-22 | 2010-10-20 | ジェンザイム、コーポレーション | 慢性的移植片拒絶反応の治療と予防のためのTGF−β拮抗薬の使用 |
NZ550217A (en) * | 2004-03-31 | 2009-11-27 | Genentech Inc | Humanized anti-TGF-beta antibodies |
EP1809324A4 (en) * | 2004-10-13 | 2009-02-25 | Univ Ohio State Res Found | METHODS OF TREATING OR PREVENTING LYMPHOPROLIFERATIVE DISORDERS ASSOCIATED WITH VIRUSES |
KR100747646B1 (ko) * | 2005-02-25 | 2007-08-08 | 연세대학교 산학협력단 | 데코린 유전자를 포함하는 유전자 전달 시스템 및 이를 포함하는 약제학적 항종양 조성물 |
JP2006295872A (ja) * | 2005-03-18 | 2006-10-26 | Matsushita Electric Ind Co Ltd | 機器固有鍵の生成方法、これを用いた機密情報処理機能を備えた機密情報lsi、これを搭載したホスト機器、これに用いられる認証機能付き記録媒体、および認証機能を備えた記録媒体付き携帯端末 |
CN101277960A (zh) | 2005-09-29 | 2008-10-01 | 默克公司 | 作为黑皮质素-4受体调节剂的酰化螺哌啶衍生物 |
EP2862867A3 (en) | 2005-10-25 | 2015-08-05 | The Johns Hopkins University | Methods and compositions for the treatment of Marfan syndrome and associated disorders |
EP1998810A4 (en) | 2006-03-13 | 2009-09-02 | Univ Johns Hopkins | INCREASE OF ENDOTHELIAL THROMBORESISTENTEN |
US8173629B2 (en) | 2006-09-22 | 2012-05-08 | Merck Sharp & Dohme Corp. | Method of treatment using fatty acid synthesis inhibitors |
PL2083863T3 (pl) * | 2006-10-03 | 2015-08-31 | Genzyme Corp | Przeciwciała przeciwko TGF-beta do stosowania w leczeniu niemowląt obarczonych ryzykiem rozwinięcia się dysplazji oskrzelowo-płucnej |
US9053063B2 (en) | 2007-02-21 | 2015-06-09 | At&T Intellectual Property I, Lp | Method and apparatus for authenticating a communication device |
EP2145884B1 (en) | 2007-04-02 | 2014-08-06 | Msd K.K. | Indoledione derivative |
HUE027831T2 (en) | 2010-03-12 | 2016-11-28 | Genzyme Corp | Combination therapy for breast cancer |
EP2660314A4 (en) | 2010-12-27 | 2014-09-03 | Lsip Llc | IPS CELLS AND METHOD FOR THEIR PRODUCTION |
US20120238727A1 (en) * | 2011-03-14 | 2012-09-20 | Catalent Pharma Solutions Llc | Decorin compositions and use thereof |
EP2737083A1 (en) | 2011-07-27 | 2014-06-04 | INSERM (Institut National de la Santé et de la Recherche Scientifique) | Methods for diagnosing and treating myhre syndrome |
WO2013062544A1 (en) | 2011-10-26 | 2013-05-02 | Seattle Children's Research Institute | Cysteamine in the treatment of fibrotic disease |
WO2013100208A1 (ja) | 2011-12-28 | 2013-07-04 | 京都府公立大学法人 | 角膜内皮細胞の培養正常化 |
WO2014176198A1 (en) | 2013-04-22 | 2014-10-30 | Catalent Pharma Solutions, Llc | Veterinary decorin compositions and use thereof |
WO2015064768A1 (ja) | 2013-10-31 | 2015-05-07 | 京都府公立大学法人 | 角膜内皮の小胞体細胞死関連疾患治療薬 |
WO2016187312A1 (en) | 2015-05-18 | 2016-11-24 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and compositions for treating an alphavirus infection |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU624789B2 (en) * | 1987-02-19 | 1992-06-25 | Amgen, Inc. | Purified platelet-derived growth factor and methods for purification thereof |
US5583103A (en) * | 1988-06-28 | 1996-12-10 | La Jolla Cancer Research Foundation | Inhibition of transforming growth factor beta activity |
-
1989
- 1989-06-23 AU AU38653/89A patent/AU633011B2/en not_active Ceased
- 1989-06-23 JP JP1507543A patent/JP2887325B2/ja not_active Expired - Fee Related
- 1989-06-23 WO PCT/US1989/002770 patent/WO1990000194A1/en active Application Filing
- 1989-06-24 AT AT89730152T patent/ATE120235T1/de not_active IP Right Cessation
- 1989-06-24 EP EP89730152A patent/EP0349480B1/en not_active Expired - Lifetime
- 1989-06-24 ES ES89730152T patent/ES2070926T3/es not_active Expired - Lifetime
- 1989-06-24 DE DE68921803T patent/DE68921803T2/de not_active Expired - Fee Related
- 1989-06-27 CA CA000604090A patent/CA1340112C/en not_active Expired - Fee Related
-
1990
- 1990-12-27 FI FI906411A patent/FI906411A0/fi not_active Application Discontinuation
- 1990-12-28 DK DK306890A patent/DK306890D0/da not_active Application Discontinuation
-
1991
- 1991-01-22 US US07/645,339 patent/US5726149A/en not_active Expired - Lifetime
-
1995
- 1995-06-02 US US08/458,830 patent/US6046162A/en not_active Expired - Fee Related
-
1996
- 1996-03-18 JP JP8061486A patent/JPH09117278A/ja active Pending
-
2002
- 2002-05-30 JP JP2002158174A patent/JP2003034651A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU3865389A (en) | 1990-01-23 |
EP0349480B1 (en) | 1995-03-22 |
DK306890A (da) | 1990-12-28 |
JP2887325B2 (ja) | 1999-04-26 |
ES2070926T3 (es) | 1995-06-16 |
JPH09117278A (ja) | 1997-05-06 |
DK306890D0 (da) | 1990-12-28 |
JP2003034651A (ja) | 2003-02-07 |
CA1340112C (en) | 1998-11-03 |
AU633011B2 (en) | 1993-01-21 |
JPH03503846A (ja) | 1991-08-29 |
EP0349480A1 (en) | 1990-01-03 |
US6046162A (en) | 2000-04-04 |
US5726149A (en) | 1998-03-10 |
DE68921803T2 (de) | 1995-07-13 |
WO1990000194A1 (en) | 1990-01-11 |
ATE120235T1 (de) | 1995-04-15 |
DE68921803D1 (de) | 1995-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI906411A0 (fi) | Foerhindring av cellfoeroekning med decorin. | |
DE69032406D1 (de) | Wundheilmittel enthaltend heparanase | |
EP0123811A3 (en) | The use of the gal 1 yeast promoter | |
EP0353893A3 (en) | Cell culture bioreactor | |
GR3035603T3 (en) | Mammals lacking expression of cd28 transgenic | |
AU3969689A (en) | Bio-reactor cell culture process | |
ES2000510A6 (es) | Procedimiento para la obtencion del enzima rldm tm degradantes de lignina. | |
AU8138582A (en) | Cooling of carbon fibre gasification vessel | |
ZA917561B (en) | Media for culture of mammalian cells | |
EP0219791A3 (en) | Process for culturing recombinant cells | |
IL72095A0 (en) | Plant growth medium and its use for suspension cell culture | |
AU586330B2 (en) | Process for maximum middle distillate production with minimum hydrogen consumption | |
AU3857185A (en) | Cell culturing with gas sparging | |
NO905610L (no) | Undertrykkelse av celleproliferasjon ved hjelp av decorin. | |
EP0193883A3 (en) | Well forming apparatus | |
DE3569613D1 (en) | Arrangement for measuring the static life of optical fibres | |
AU583978B2 (en) | Fermentation of bacteria at high productivities | |
AU7169981A (en) | Liquefaction of coal with hydrogen | |
AU2163588A (en) | Stabilization of enzymes by inhibiting proteolytic enzyme contaminants | |
AU2862584A (en) | Durchflussmengenmessgerat fur gase und verwendung desselben | |
IL80901A0 (en) | Growth-promoting cell culture medium and process for the cultivation of cells employing the same | |
ZA846919B (en) | Genetically engineered microorganism for the massive production of alpha amylase | |
GB8432385D0 (en) | Plant cell suspension cultures | |
GR3015318T3 (en) | Method for culturing cells. | |
GB8721950D0 (en) | Cell culture reactor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
FD | Application lapsed |
Owner name: LA JOLLA CANCER RESEARCH FOUNDATION |